178 related articles for article (PubMed ID: 20101209)
1. Molecular pathogenesis of peripheral neuroblastic tumors.
Janoueix-Lerosey I; Schleiermacher G; Delattre O
Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
[TBL] [Abstract][Full Text] [Related]
2. Recent insights into the biology of neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Delattre O
Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
[TBL] [Abstract][Full Text] [Related]
3. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
[TBL] [Abstract][Full Text] [Related]
4. Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
Ohira M; Nakagawara A
Cancer Sci; 2010 Nov; 101(11):2295-301. PubMed ID: 20731666
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic mutations of ALK in neuroblastoma.
Ogawa S; Takita J; Sanada M; Hayashi Y
Cancer Sci; 2011 Feb; 102(2):302-8. PubMed ID: 21205076
[TBL] [Abstract][Full Text] [Related]
6. Rare occurrence of PHOX2b mutations in sporadic neuroblastomas.
Serra A; Häberle B; König IR; Kappler R; Suttorp M; Schackert HK; Roesner D; Fitze G
J Pediatr Hematol Oncol; 2008 Oct; 30(10):728-32. PubMed ID: 19011468
[TBL] [Abstract][Full Text] [Related]
7. Germline gain-of-function mutations of ALK disrupt central nervous system development.
de Pontual L; Kettaneh D; Gordon CT; Oufadem M; Boddaert N; Lees M; Balu L; Lachassinne E; Petros A; Mollet J; Wilson LC; Munnich A; Brugière L; Delattre O; Vekemans M; Etchevers H; Lyonnet S; Janoueix-Lerosey I; Amiel J
Hum Mutat; 2011 Mar; 32(3):272-6. PubMed ID: 21972109
[TBL] [Abstract][Full Text] [Related]
8. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
[TBL] [Abstract][Full Text] [Related]
9. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
[TBL] [Abstract][Full Text] [Related]
10. Oligogenic inheritance in neuroblastoma.
Longo L; Tonini GP; Ceccherini I; Perri P
Cancer Lett; 2005 Oct; 228(1-2):65-9. PubMed ID: 15923081
[TBL] [Abstract][Full Text] [Related]
11. [New insights into the genetic basis of neuroblastoma].
Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J
Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957
[TBL] [Abstract][Full Text] [Related]
12. Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy.
Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schönherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
Cancer Res; 2011 Jan; 71(1):98-105. PubMed ID: 21059859
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors.
Kwon MJ; Choi YL; Sung KW; Kang SY; Park SM; Choi SY; Kim JS; Suh YL
Pathol Res Pract; 2011 Oct; 207(10):634-9. PubMed ID: 21940108
[TBL] [Abstract][Full Text] [Related]
14. PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma.
Longo L; Borghini S; Schena F; Parodi S; Albino D; Bachetti T; Da Prato L; Truini M; Gambini C; Tonini GP; Ceccherini I; Perri P
Int J Oncol; 2008 Nov; 33(5):985-91. PubMed ID: 18949361
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
[TBL] [Abstract][Full Text] [Related]
16. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
17. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
18. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
[TBL] [Abstract][Full Text] [Related]
19. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma.
Cazes A; Louis-Brennetot C; Mazot P; Dingli F; Lombard B; Boeva V; Daveau R; Cappo J; Combaret V; Schleiermacher G; Jouannet S; Ferrand S; Pierron G; Barillot E; Loew D; Vigny M; Delattre O; Janoueix-Lerosey I
Cancer Res; 2013 Jan; 73(1):195-204. PubMed ID: 23139213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
